Experts praise FDA’s cautious approach to psychedelic medicine
As the Food and Drug Administration inches toward possible approval of psilocybin, a psychedelic medicine, experts are praising its methodical approach.
To access this post, you must purchase Premium Subscription - Daily Email and Full Website Access.